These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20031860)

  • 1. Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.
    Arnold SV; Morrow DA; Lei Y; Cohen DJ; Mahoney EM; Braunwald E; Chan PS
    Circ Cardiovasc Qual Outcomes; 2009 Jul; 2(4):344-53. PubMed ID: 20031860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
    Arnold SV; Morrow DA; Wang K; Lei Y; Mahoney EM; Scirica BM; Braunwald E; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):107-15. PubMed ID: 20031797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of depression, angina, and quality of life after acute coronary syndromes.
    Rumsfeld JS; Magid DJ; Plomondon ME; Sales AE; Grunwald GK; Every NR; Spertus JA
    Am Heart J; 2003 Mar; 145(3):493-9. PubMed ID: 12660673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between depression and worse disease-specific functional status in outpatients with coronary artery disease.
    Spertus JA; McDonell M; Woodman CL; Fihn SD
    Am Heart J; 2000 Jul; 140(1):105-10. PubMed ID: 10874270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
    Melloni C; Newby LK
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of care for new versus recurrent acute coronary syndrome patients.
    Shetty S; Halpern R; McCollam PL
    J Med Econ; 2008; 11(1):81-99. PubMed ID: 19450112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of payment in Thai acute coronary syndrome patients.
    Moleerergpoom W; Kanjanavanit R; Jintapakorn W; Sritara P
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():21-31. PubMed ID: 18431883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after acute coronary syndrome admission to primary versus tertiary Veterans Affairs medical centers: the Veterans Affairs Access to Cardiology study.
    Rumsfeld JS; Magid DJ; Peterson ED; Plomondon ME; Petersen LA; Grunwald GK; Every NR; Sales AE
    Am Heart J; 2006 Jan; 151(1):32-8. PubMed ID: 16368288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of difficulty affording health care on health status after coronary revascularization.
    Spertus J; Decker C; Woodman C; House J; Jones P; O'Keefe J; Borkon AM
    Circulation; 2005 May; 111(20):2572-8. PubMed ID: 15883210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
    Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
    J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
    Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Skene A; McCabe CH; Braunwald E;
    Am Heart J; 2006 Jun; 151(6):1186.e1-9. PubMed ID: 16781216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
    McCollam P; Etemad L
    J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).
    Claude J; Schindler C; Kuster GM; Schwenkglenks M; Szucs T; Buser P; Osswald S; Kaiser C; Grädel C; Estlinbaum W; Rickenbacher P; Pfisterer M;
    Eur Heart J; 2004 Dec; 25(24):2195-203. PubMed ID: 15589636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The Coronary Artery Disease in General Practice (CADENCE) Study.
    Beltrame JF; Weekes AJ; Morgan C; Tavella R; Spertus JA
    Arch Intern Med; 2009 Sep; 169(16):1491-9. PubMed ID: 19752407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
    Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
    Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hospitalization and follow-up care costs among patients hospitalized with ACS treated with a stent and clopidogrel.
    Chastek B; Riedel AA; Wygant G; Hauch O
    Curr Med Res Opin; 2009 Dec; 25(12):2845-52. PubMed ID: 19831706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
    Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.